Allogeneic transplantation across major HLA barriers

Area of Science:

• Hematology
• Immunology
• Transplantation Medicine

Background:

• Limited availability of HLA-matched sibling donors for allogeneic stem cell transplantation.
• Significant advancements in medical management and graft preparation enable the use of alternative donors.

Purpose of the Study:

• To evaluate the efficacy and safety of using alternative donor sources for allogeneic stem cell transplantation.
• To assess engraftment and graft-versus-host disease (GVHD) rates with alternative donors.

Main Methods:

• Utilizing safer non-cytotoxic therapies for immune ablation.
• Optimizing graft preparation to reduce T-lymphocytes and/or increase CD34+ cell doses.
• Implementing post-transplant GVHD and infection prophylaxis.

Main Results:

• Achieved engraftment rates exceeding 95%.
• Reported grade II-IV graft-versus-host disease (GVHD) rates below 25%.
• Disease-free survival rates comparable to other alternative donor sources.

Conclusions:

• Alternative donors, including haplo-identical related donors, are effective for allogeneic stem cell transplantation.
• Improved transplant protocols enhance engraftment and reduce GVHD, making these options accessible.
• Outcomes are influenced by disease status, patient performance, and age.